baber/WOPTO huggingface dataset:
Patent WO-0192277-A8 (WO)
Title: Metallocenes utilises comme transducteurs du signal en vue de la detection d'evenements chimiques ou biologiques
Inventor: BAMDAD CYNTHIA C
IPC: G01N27/416
Filed: 2001-05-25
Abstract: L'invention concerne des compositions, des kits, des procédés et des espèces relatifs à des entités électroactives pouvant servir d'entités de signalisation dans le cadre d'analyses chimiques et/ou biochimiques. Lesdites espèces électroactives peuvent être des métallocènes, notamment des ferrocènes, renfermant des substituants qui ont une incidence sur le potentiel d'oxydoréduction (potentiel rédox) desdites espèces. La régulation du potentiel rédox de ces espèces permet donc d'utiliser plusieurs espèces pour une seule analyse de signalisation simultanée de différents événements de liaison, chaque espèce ayant un potentiel rédox différent. En outre, le procédé selon l'invention permet d'utiliser des espèces dont le potentiel rédox est inférieur à 490mV, ce qui facilite la détection de la signalisation, sur une large plage de potentiels, en présence de fluides biologiques.
Patent WO-02079468-A8 (WO)
Title: Procede destine a ameliorer la complementarite d'un heteroduplex
Inventor: PADGETT HAL S
IPC: C12N15/10
Filed: 2002-02-01
Abstract: L'invention concerne un procédé in vitro destiné à améliorer la complémentarité d'une séquence polynucléotidique hétéroduplex. Ce procédé consiste à hybrider des brins opposés afin de former un polynucléotide duplex avec des mésappariements. Le polynucléotide hétéroduplex est combiné avec une quantité efficace d'enzymes possédant une activité de clivage de brin, une activité exonucléase de 5' en 3', et une activité polymérase, et laissant un temps suffisant pour accroître le pourcentage de complémentarité dans l'hétéroduplex. Tous les polynucléotides hétéroduplex n'auront pas tous leurs mésappariements résolus à la complémentarité. Le polynucleotide qui en résulte est éventuellement ligaturé. Plusieurs polynucleotides différents en résultent. Aux endroits où l'un des brins opposés calibre le recodage dans l'autre brin, la complémentarité de pourcentage résultante de la séquence polynucléotidique hétéroduplex est augmentée. Les polynucleotides parents doivent être clivés en fragments avant l'hybridisation des brins hétérologues. C'est pourquoi le réassemblage n'est pas nécessaire.
Patent WO-9400806-A8 (WO)
Title: Regulateur de tension
Inventor: RIGGIO CHRIS A
IPC: G05F1/455
Filed: 1993-05-21
Abstract: L'invention décrit un dispositif et un procédé servant à réguler la tension appliquée à une charge. Le procédé comprend la réception d'une tension de réseau de courant alternatif, la génération d'une tension de régime de courant alternatif à partir de la tension de réseau de courant alternatif et l'application de ladite tension de régime à la charge. Un signal mesuré, fonction de l'intensité de la tension de régime de courant alternatif, est produit et sa moyenne est établie, afin de générer un signal de moyenne représentant la valeur moyenne du signal mesuré. La tension de régime de courant alternatif est réajustée en continu en réaction à des modifications du signal de moyenne. Le dispositif de mise en application du procédé comprend des bornes servant à recevoir une tension de réseau de courant alternatif, des moyens servant à générer une tension de régime de courant alternatif à partir de la tension de réseau de courant alternatif, des moyens de branchement servant à appliquer la tension de régime de courant alternatif à la charge, et des moyens de détection de tension servant à générer un signal mesuré fonction de l'intensité de ladite tension de régime de courant alternatif. Des moyens d'établisssement de la moyenne de signal servent à générer un signal de moyenne représentant la valeur moyenne du signal mesuré. Enfin, le dispositif comprend des moyens de modulation de tension de courant alternatif servant à ajuster la tension de régime de courant alternatif en réaction au signal de moyenne. Dans le mode de réalisation préféré du dispositif décrit par l'invention, le moyen de modulation de tension de courant alternatif comprend des moyens de réduction de tension servant à couper la tension de réseau pendant une partie de chaque cycle, la longueur de ladite partie étant déterminée par la valeur moyenne du signal mesuré. Le moyen de modulation de tension comprend éventuellement un dispositif à circuit intégré de régulation de phase servant à commander un thyristor. Le dispositif à circuit intégré de régulation de phase réagit au signal de moyenne pour générer un signal de commande servant à commander un thyristor qui interrompt la transmission de la tension de réseau vers la charge pendant ladite partie de chaque cycle.
Patent WO-0029582-A8 (WO)
Title: Cell surface receptor antigen vaccines
Inventor: SCHOLLER NATHALIE B
IPC: A61K48/00
Filed: 1999-11-17
Abstract: The invention provides compositions and methods directed to cell surface receptor antigen specific vaccines. More specifically, vaccines are provided that induce or enhance host antibody titers specific for cell surface receptor antigens and that include recombinant expression constructs containing nucleic acids encoding a target cell surface receptor antigen and one or more immune response altering molecules, or the expressed products themselves.
Patent EP-1617290-A8 (EP)
Inventor: ALLENSPACH ROLF
IPC: H01J37/317
Filed: 2004-07-13
Abstract: The present invention is related to an apparatus and method for maskless lithography. The apparatus comprises an electron accelerating chamber (10) for accelerating electrons towards a support (12) on which a substrate (15) is mountable; a photon switching unit (20,21); and an electron emission layer (22) on the photon switching unit for outcoupling the electrons into the chamber. The photon switching unit with the electron emission layer is disposed opposite to the support and outcoupled electrons are directly acceleratable towards the support.
Patent EP-1741921-A8 (EP)
Inventor: MIFUJI MASANORI
IPC: F02M61/16
Filed: 2006-07-03
Abstract: The invention relates to a fuel injection valve comprising a valve seat (31) being provided upstream from a fuel nozzle orifice (32). A first valve rod (2) opens and closes the fuel nozzle orifice (32) with axial movements relative to the valve seat (31). A spring (4) exerts the first valve rod (2) away from the valve seat (31). A stopper (6) restricts a lift amount of the first valve rod (2) lifted with a force of the spring (4). A solenoid produces a magnetic field. A magnetostrictive element (9) extends when current passes through the solenoid and shrinks when no current passes through said solenoid, and having a hysteresis in an axial deformation amount on extending and in an axial deformation amount on shrinking. A second valve rod (8) presses the first valve rod (2) onto the valve seat (31) against the force of the spring (4) when the solenoid is not energized, and allows the first valve rod (2) to move away from the valve seat (31) with exertions of an extension of the magnetostrictive element (9) and the force of said spring (4) when said solenoid is energized. Wherein the extension amount of the magnetostrictive element (9) when the first valve rod (2) is fully open is set greater than a full stroke of the first valve rod (2) from the valve seat (31) to stopper (6).
Patent EP-1961808-A8 (EP)
Inventor: THIERAUF AXEL DR
IPC: A61K35/12
Filed: 2002-05-22
Abstract: In vitro preparation of cells, tissues and organs (A) by growth on a fiber matrix derived from hydrolytically condensed silane. In vitro preparation of cells, tissues and organs (A) using a fiber matrix as: (i) cell support and/or (ii) as conducting structure for extracellular matrix (ECM) produced by the cells, also to allow the cells to adopt a spatial arrangement, to replicate and/or to achieve their genetically determined differentiation. The new feature is that the matrix is made of biodegradable and/or bioresorbable fibers produced by drawing from the spin mass. This mass consists of one or more partially or fully hydrolytically condensed silicon compounds, formed by hydrolytic condensation of SiX 4 X : hydroxy, hydrogen, halo, amino, alkoxy, acyloxy, alkylcarbonyl or alkoxycarbonyl, derived from optionally substituted, linear, branched or cyclic 1-20C alkyl residues, optionally interrupted by sulfur, oxygen or amino. An independent claim is also included for (A) produced this way. ACTIVITY : Vulnerary. MECHANISM OF ACTION : None given.
Patent BR-PI0506232-A8 (BR)
Title: processo de detecção de padrões individuais por meio de perfil térmico
Inventor: CARMEN DÉA MORAES PATARO
IPC: G06K9/00
Filed: 2005-12-07
Abstract: processo de detecção de padrões individuais por meio de perfil térmico a presente invenção refere-se a um processo de identificação de pessoas empregando-se padrões térmicos das faces de diversos indivíduos, em que o registro de temperatura média em pontos específicos, e em suas vizinhanças, do rosto com ou sem máscara, é obtido por um equipamento de medição térmica, sem contato com a pele, que capta a radiação infravermelha. com este sistema, pessoas usando um tipo de máscara, também foram reconhecidas através das mesmas. os resultados obtidos mostraram que os padrões térmicos faciais variam de indivíduo para indivíduo. uma das novidades marcantes da presente invenção demonstra que padrões de temperaturas faciais podem ser empregados para a identificação individual. a grande vantagem deste método sobre os já existentes consiste na possibilidade de se identificarem indivíduos disfarçados ou mascarados até mesmo em completa escuridão.
Patent BR-PI0914081-A8 (BR)
Title: Dispositivo de expansão de stents
Inventor: PETER PAUL ZILLA
IPC: A61M25/10
Filed: 2009-10-08
Abstract: DISPOSITIVO DE EXPANSÃO DE STENTS Um dispositivo de expansão de stents (1) sobre o qual um stent (2) pode ser fixado para fins de liberação em uma posição operativa em um corpo humano. O dispositivo compreende uma série de asas alongadas (16), cada uma das quais com um comprimento consistente com o comprimento de um stent a ser expandido utilizando o dispositivo de expansão, em que as asas são dispostas em circunferência em volta de um corpo central (10) que se estende a partir de um cateter (14) e é operável por meio dele. As asas são móveis entre uma posição de liberação movida radialmente e posições expandidas nas quais são deslocadas radialmente para fora do corpo. Um trajeto de fluxo (105) é definido no lado interno das asas nas suas posições expandidas e uma válvula temporária (68) é fornecida nesse trajeto de fluxo permitir o fluxo de sangue através do trajeto de fluxo predominantemente em uma direção. Um balão anular inflável (80) é preferencialmente fornecido sobre as asas para causar expansão final do stent. Os braços posicionadores, (40) são expandidos a partir do corpo para assistir no posicionamento do corpo no interior de uma válvula cardíaca natural (101).
Patent BR-PI0917094-A8 (BR)
Title: Métodos para identificação de fibra de planta processada, para análise do genoma de uma planta de algodão produtora de fibra, e para o isolamento de dna de ocorrência natural de fibras de planta de algodão processadas, uso dos referidos métodos, bem como métodos para o isolamento de um dna de ocorrência natural de tecido ou de pano tricotado, para determinar as quantidades relativas de diferentes fibras de planta de algodão em uma mistura de fibras de algodão processadas, e para certificar a identidade de fibras de algodão comercializadas
Inventor: ANTONIO ARIOLI
IPC: C12Q1/68
Filed: 2009-08-06
Abstract: MÉTODOS PARA CARACTERIZAÇÃO E IDENTIFICAÇÃO DE FIBRA DE PLANTA. A presente invenção refere-se a métodos que são providos para o isolamento de macromoléculas biológicas incluindo peptídeos, proteínas, e ácidos nucleicos de fibras de planta madura, tais como fibras de planta e de têxteis. As macromoléculas biológicas podem ser usadas para caracterizar a fibra de planta (fonte, origem, composição genômica de produção de planta etc.).
Patent BR-PI1002326-A8 (BR)
Title: dispositivo de ensaio compreendendo zonas de reação seriais
Inventor: Gerd Rundström
IPC: G01N33/00
Filed: 2010-07-01
Abstract: dispositivo de ensaio compreendendo zonas de reação seriais. a presente invenção refere-se a um dispositivo de análise compreendendo um substrato tendo pelo menos uma zona de adição de amostra, pelo menos um sumidouro e pelo menos um curso de fluxo conectado a pelo menos uma zona de adição de amostra e a pelo menos um sumidouro, em que o pelo menos um curso de fluxo compreende projeções substancialmente verticais à superfície do referido substrato e tendo uma altura (h), um diâmetro (d) e espaçamento recíproco (t1, t2), de modo que fluxo capilar lateral de uma amostra de liquido seja obtido, em que o dispositivo compreende pelo menos duas zonas de reação em série, em que cada zona de reação é adaptada para facilitar a medição de uma resposta que origina-se de um e do mesmo analito e em que as pelo menos duas zonas de reação são posicionadas para permitir o cálculo da concentração de pelo menos um analito. as vantagens incluem que um valor mais preciso pode ser calculado, variações são reduzidas e uma estimativa da incerteza da resposta pode ser calculada.
Patent AU-2002368172-A8 (AU)
Title: Transverse plasma injector ignitor
Inventor: CHABOKI AMIR
IPC: F42B5/08
Filed: 2002-01-07
Abstract: A plasma injector for use in munitions having a central axis. The plasma injector has a stub case, a tube, an anode, a cathode, and a conductive wire. The tube has a first end, a second end, and a central bore extending therethrough. The tube has at least one aperture that is operably connected to the central bore. The tube is attached to the stub case substantially transverse to the central axis. The anode is positioned proximate the first end. The cathode is positioned proximate the second end. The conductive wire extends through the central bore between the anode and the cathode and operably connects the anode and the cathode.
Patent AU-2003285769-A8 (AU)
Title: A substrate for epitaxy and a method of preparing the same
Inventor: GARCZYNSKI JERZY
IPC: H01L33/32
Filed: 2003-12-11
Abstract: The substrate is used for opto-electric or electrical devices and comprises a layer of nitride grown by means of vapor phase epitaxy growth wherein both main surfaces of the nitride substrate are substantially consisting of non N-polar face and N-polar face respectively and the dislocation density of the substrate is 5×105/cm2 or less. Therefore, the template type substrate has a good dislocation density and a good value of FWHM of the X-ray rocking curve from (0002) plane less than 80, so that the resulting template type substrate is very useful for the epitaxy substrate from gaseous phase such as MOCVD, MBE and HVPE, resulting in possibility of making good opto-electric devices such as Laser Diode and large-output LED and good electric devices such as MOSFET.
Patent AU-2009305715-A8 (AU)
Title: Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
Inventor: WANG XINHUI
IPC: G01N33/574
Filed: 2009-10-15
Abstract: Disclosed herein are isolated human monoclonal antibodies, and functional fragments thereof, that specifically bind HMW-MAA. Nucleic acids encoding these antibodies, expression vectors including these nucleic acid molecules, and isolated host cells that express the nucleic acid molecules are also disclosed. The antibodies can be used to detect HMW-MAA in a sample. Methods of diagnosing cancer, or confirming a diagnosis of cancer, are disclosed herein that utilize these antibodies. Methods of treating a subject with cancer are also disclosed.
Patent AU-2011247834-A8 (AU)
Title: Child carrier
Inventor: GUNTER MARK
IPC: A45F4/00
Filed: 2011-11-07
Abstract: A child carrier that may be worn by an adult and support a child in either a forward-facing or rearward-facing position is provided. The child carrier may include a pouch assembly including a 5 bottom portion and a front portion, where the weight of the child in a first position is configured to be substantially supported by the bottom portion. The child carrier may further include a removable insert configured to be removably installed into the child carrier, where when the removable insert is installed in the child carrier, the weight of the child in a second position is configured to be substantially supported by the removable insert. The child carrier may further include a harness 0 assembly attached to the pouch assembly, where the removable insert may be configured to be attached at one end to the pouch assembly and at another end to the harness assembly.
Patent AU-2016270005-A8 (AU)
Title: Plant growth-promoting rhizobacteria infused fertilizer
Inventor: ROACH TOMMY
IPC: C05F11/08
Filed: 2016-03-21
Abstract: The present invention is a plant fertilizer product comprising at least one organic potassium source and at least one bacillus strain of rhizobacteria.
Patent AU-2019302833-A8 (AU)
Title: Hyaluronic acid filler having high lift capacity and low injection force
Inventor: JANG CHEOL
IPC: C08L5/08
Filed: 2019-07-09
Abstract: A hyaluronic acid filler according to the present invention not only exhibits an improved high lift capacity so as to maintain the shape of the skin for a long period of time while having a low probability for movement when injected into the skin, but also has a very low injection pressure during injection so as to reduce wrinkles and restore or expand the volume of soft tissues such as that of the cheeks, breasts, nose, lips, and buttocks, and is excellent when used for contour correction. Even when crosslinking agents are used sparingly in the manufacturing process, the hyaluronic acid filler has increased residence time in the human body and causes patients less pain.
Patent AU-2019480813-A8 (AU)
Title: Methods for determining chromosome aneuploidy and constructing classification model, and device
Inventor: ZHANG HONGYUN
IPC: G16B20/10
Filed: 2019-12-31
Abstract: Provided is a method for determining whether a fetus has chromosome aneuploidy, the method comprising: (1) acquiring nucleic acid sequencing data of a sample derived from a pregnant woman; (2) determining, on the basis of the nucleic acid sequencing data, the fetal concentration of the sample from the pregnant woman and a back-estimated concentration of a predetermined chromosome; (3) determining a first feature on the basis of the difference between a back-estimated concentration of a chromosome to be tested and a back-estimated concentration of a second comparison chromosome, and determining a second feature on the basis of the difference between the back-estimated concentration of the chromosome to be tested and the fetal concentration; and (4) on the basis of the first feature and the second feature, using corresponding data of a control sample to determine whether the fetus has aneuploidy for the chromosome to be tested. The control sample comprises a positive sample and a negative sample, the positive sample has aneuploidy for the chromosome to be tested, and the negative sample does not have aneuploidy for the chromosome to be tested.
Patent WO-2005084662-A8 (WO)
Title: Agent d'extraction d'euphorbia lunulate bge et son procede de production et d'utilisation
Inventor: WANG LIYAN
IPC: A61P1/04
Filed: 2004-03-04
Abstract: L'invention concerne un procédé permettant d'extraire des composés actifs d'une plante médicinale, l'Euphorbia Lunulate Bge. Ledit procédé comprend les étapes suivantes: les agents d'extraction de l'Euphorbia Lunulate Bge sont isolés et extraits à l'état brut; les agents d'extraction de solvants organiques font l'objet d'une inhibition d'activité de NO, puis sont isolés lorsqu'ils présentent une activité élevée d'inhibition de NO et aucune toxicité; puis les compositions isolées sont soumises à une nouvelle inhibition de l'activité de NO, puis sont raffinées; le composé unique obtenu fait l'objet d'une inhibition d'activité de NO et d'une identification physique et chimique afin de définir sa structure. Le composé obtenu présente une activité d'inhibition de production de NO dans laquelle la structure du composé 1-3 est représentée par les formules (1), (2) et (3).
Patent WO-2010003312-A8 (WO)
Inventor: LI LI
IPC: A61N1/00
Filed: 2009-07-07
Abstract: An intellect heating fabric weaved by common textile materials (108) and conductive textile materials (106) comprises: heating units (107,201) which are spreaded over the fabric to provide heating for specific parts of user's body; input terminal (101) which is connected with external power supply for providing power to the heating units (107,201). Furthermore, the conductive textile materials (106) blend with the common textile materials (108) in order to connect the input terminal (101) with the heating units (107,201).
Patent WO-2013104092-A8 (WO)
Title: Process for producing mesophase pitch by hydrogenation of high-temperature coal tar
Inventor: ZHAO HONGMEI
IPC: C10C3/00
Filed: 2012-04-06
Abstract: Disclosed is a process for producing mesophase pitch by hydrogenation of high-temperature coal tar, comprising removing salts and quinoline insolubles from the high-temperature coal tar to obtain a clear oil; using the clear oil as a hydrogenation feed oil, or pre-distilling the clear oil to obtain a bottom component with a boiling point higher than 230°C and formulating the bottom component into a hydrogenation feed oil; refining the hydrogenation feed oil by catalytic hydrogenation to obtain a refined hydrogenated oil; distilling the refined hydrogenated oil to obtain hydrogenated pitch; subjecting the hydrogenated pitch to thermal condensation polymerisation to obtain the mesophase pitch. The process has features such as an easily controllable degree of hydrogenation, complete removal of impurities, good raw material flowability, not being susceptible to carbon deposition and coking during the process, and not tending to block the reactor. The product has a high mesophase content, a low softening point and a low impurity content.
Patent WO-2006021378-A8 (WO)
Title: Derives de dihydropteridinone, procede pour les produire et utilisation de ceux-ci comme medicaments
Inventor: GRAUERT MATTHIAS
IPC: C07D475/04
Filed: 2005-08-19
Abstract: La présente invention concerne de nouvelles dihydroptéridinones de formule générale (I) dans laquelle les radicaux L, R1, R2, R3, R4 et R5 ont les significations mentionnées dans les revendications et dans la description, leurs isomères, des procédés pour produire ces dihydroptéridinones, ainsi que leur utilisation comme médicaments
Patent WO-2007014743-A8 (WO)
Inventor: FEY GEORG H
IPC: C07K14/21
Filed: 2006-07-31
Abstract: A single-chain immunotoxin composition and method of treatment with the composition is disclosed. Preferably, the immunotoxin is comprised of a CD33- specific single chain Fv antibody fragment and a genetically engineered variant of Pseudomonas Exotoxin A (ETA). A preferred engineered Exotoxin A is referred to ETA' and may includes a KDEL peptide at its C-terminus, a cellular peptide mediating improved retrograde transport to the endoplasmic reticulum (ER). The immunotoxin compound may be formulated with a carrier and administered into patients where the antibody portion binds to CD33-positive cells and kills those cells to provide an effective treatment for diseases such as human myeloid leukemia.
Patent WO-2008131875-A8 (WO)
Title: Bourrelet d'étanchéité, en particulier pour garniture d'étanchéité de hayons et de portières sur des carrosseries de véhicules
Inventor: HIRSL MIROSLAV
IPC: B60J10/00
Filed: 2008-04-18
Abstract: L'invention concerne un bourrelet d'étanchéité, en particulier pour garniture d'étanchéité de hayons sur des carrosseries de véhicules, comprenant une zone transversale (9) qui est constituée par une matière d'étanchéité souple, en particulier, plastiquement déformable, comparativement à la matière du bourrelet adjacente, caractérisé en ce que la zone transversale (9) est fabriquée par extrusion, de préférence par co-extrusion avec le bourrelet d'étanchéité restant.